Current Illinois CancerCare Clinical Trials

Netupitant/Palonosetron Hydrochloride and Dexamethasone With or Without Prochlorperazine or Olanzapine in Improving Chemotherapy-Induced Nausea and Vomiting in Patients With Breast Cancer

Study Number: URCC 16070

Study Summary:
This randomized phase III trial studies how well netupitant/palonosetron hydrochloride and dexamethasone with prochlorperazine or olanzapine work compared to netupitant/palonosetron hydrochloride and dexamethasone in improving chemotherapy-induced nausea and vomiting in patients with breast cancer. Antiemetic drugs, such as prochlorperazine and olanzapine, may help lessen nausea and vomiting in patients with breast cancer treated with chemotherapy.

Status: Open

Study Coordinator(s)
  • Courtney, 309-243-3660 cbrown@illinoiscancercare.com
  • Kelsey, 309-243-3618 kfay@illinoiscancercare.com
  • Erica, 309-243-3626 eraynor@illinoiscancercare.com

Study Link

« Search Again
WordPress PopUp Plugin